製品の概要

  • 製品名Loperamide hydrochloride
  • 製品の詳細
    Selective μ opioid receptor agonist
  • 生理活性の詳細Peripheral selective μ opioid receptor agonist. Ki values are 3, 48 and 1156 nM for opioid receptor subtypes μ, δ and κ, respectively. High doses allow central μ receptor activation. Antidiarrheal, antipruritic and antihyperalgesic agent.
  • 精製度> 99%

製品の特性

    Loperamide hydrochloride (ab120713) 使用論文

    This product has been referenced in:
    • di Bosco AM  et al. Binding site of loperamide: automated docking of loperamide in human mu- and delta-opioid receptors. Chem Biol Drug Des 71:328-35 (2008). Read more (PubMed: 18284554) »
    • DeHaven-Hudkins DL  et al. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. J Pharmacol Exp Ther 289:494-502 (1999). Read more (PubMed: 10087042) »
    • Banerjee AK  et al. Acute diarrhoeal disease in rabbit: bacteriological diagnosis and efficacy of oral rehydration in combination with loperamide hydrochloride. Lab Anim 21:314-7 (1987). Read more (PubMed: 3695388) »
    • Mackerer CR  et al. Loperamide binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther 199:131-40 (1976). Read more (PubMed: 10422) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120713.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"